Lumiata

San Mateo, CA, USA All United States companies → — Founded 2013

Clinical AI Platform Healthcare Analytics / BI

Hospital Medicine Internal Medicine Nephrology

Clinical Decision Support & Reference Population Health Analytics

Acquired (by Somatus in April 2022) — $45M, $47M

Website Claim this company

Products

Lumiata AI

Lumiata

Clinical Decision Support & Reference

Lumiata offers AI-driven predictive analytics and pre-trained models to identify high-risk patients, manage costs, and enable proactive interventions and personalized care.

Subscription-based

See all 1 product →

About Lumiata

Lumiata is a healthcare AI company that develops a health analytics platform designed to provide predictive and prescriptive insights for healthcare organizations. Their platform leverages artificial intelligence and machine learning to analyze vast amounts of healthcare data, including over 100 million patient records, 35,000 physician curation hours, and 50 million articles mined from PubMed. This allows them to predict health, risk, and cost at both individual patient and population levels in real-time.

For physicians, Lumiata’s platform offers tools to identify at-risk patients, optimize treatment plans, and enhance operational efficiency. The company’s core technological engine, the Lumiata Medical Graph, analyzes hundreds of healthcare datasets within the context of clinical practice and medical knowledge to map out insights on current and future health trajectories. This approach aims to mimic how physicians think by analyzing connections and causalities, providing personalized and actionable analytics. The platform can also provide evidentiary clinical rationale with each prediction, fostering stronger alignment among clinical stakeholders.

Lumiata’s AI models are designed to predict high-cost healthcare claims, disease onset, and group costs, enabling earlier interventions and improved patient outcomes. The platform integrates disparate healthcare-specific datasets, including claims, EHR data, labs, and pharmacy information, and makes them machine learning-ready. This allows for the creation of a comprehensive longitudinal person record for personalized analytics. Lumiata’s solutions are intended to help healthcare organizations reduce costs and provide more responsible and responsive care.

Focus Areas

AI healthcare analytics cost prediction risk management patient data disease onset predictive models care coordination population health management underwriting disease management

Business Intelligence

Key Investors	Allegis Capital, Alumni Ventures, AmeriHealth, Blue Venture Fund, Defy.vc, Khosla Ventures, AllegisNL Capital, Castor Ventures, Valeo Ventures
Partnerships	FGC Health, San Mateo Medical Center (pilot program)
Acquisitions	Acquired by Somatus in 2022
Technology	Cloud-based AI platform, Lumiata Medical Graph (Snowflake platform), Lumiata AI Studio, integrates with existing systems through APIs, utilizes Google Cloud AI infrastructure

At a glance

Founded 2013

HQ San Mateo, CA, USA · United States

Team size 27 (as of 2022), 45 (as of current information), 50-100 (as of current information)

CEO Dilawar Syed (as of January 2021, though the company's assets were acquired by Somatus in April 2022, and Jessica McCarthy was Acting CEO and COO at the time of acquisition and joined Somatus)

Funding Acquired (by Somatus in April 2022) — $45M, $47M

Products 1

Visit site

Products by Lumiata

1 product in the directory

Lumiata AI

Lumiata

Clinical Decision Support & Reference

Lumiata offers AI-driven predictive analytics and pre-trained models to identify high-risk patients, manage costs, and enable proactive interventions and personalized care.

Subscription-based

Reviews & Opinions

No web reviews on file yet for Lumiata. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Lumiata.

Loading videos...

Videos load interactively. If none appear, search YouTube for Lumiata →

View all on YouTube

Press & Coverage

HCI Innovation Group

Kidney Care Provider Somatus Acquires Lumiata | HCI Innovation Group

Somatus, a value-based kidney care company, acquired strategic assets from Lumiata, a healthcare-specific AI platform, to enhance its predictive capabilities for identifying high-cost claimants and disease progression. This acquisition aims to reduce costs for providers and health plans and address healthcare disparities.

2022-05

Business Wire

Somatus Enhances Predictive Capabilities and Risk Accuracy Through Acquisition of Lumiata - Business Wire

Somatus, a leading value-based kidney care company, announced the acquisition of strategic assets from Lumiata, a healthcare-specific AI platform. This move is expected to increase the precision of identifying individuals with chronic kidney disease earlier and accelerate solutions for health inequities.

2022-04

AI Business

Lumiata raises $14m to bring more machine learning to healthcare | AI Business

Lumiata, a startup developing ML model creation and management tools for the healthcare industry, raised $14 million in Series B funding. The company plans to use the funds to scale its platform, invest in customer acquisition, and open a new office in Guadalajara, Mexico.

2021-01

PR Newswire

Healthcare Specific AI Platform Lumiata Raises Series B Funding - PR Newswire

Lumiata completed a $14 million Series B funding round led by Defy.vc and AllegisNL Capital, with participation from existing investors Khosla Ventures and Blue Venture Fund. The funding will be used to scale its enterprise-grade AI platform and invest in customer acquisition and success.

2021-01

PR Newswire

Lumiata Extends Data Preparation for Healthcare Customers on AWS and Azure in Partnership with Ascend.io - PR Newswire

Lumiata announced a partnership with Ascend.io to provide customers with access to its proprietary data preparation process, ensuring seamless operation regardless of their cloud environment (AWS or Azure). This collaboration enhances Lumiata's offering with a cloud-agnostic solution for data management.

2021-02

PR Newswire

Lumiata Healthcare Underwriting Models Wins Prestigious IAAI Deployed Application Award

Lumiata won the IAAI Deployed Application Award for its paper on accurate and interpretable machine learning for transparent health insurance pricing. The award recognizes deployed AI applications with measurable benefits and emerging areas of AI technology.

2020-11

PR Newswire

Lumiata Partners with FGC Health for AI-Based Predictive Models to Identify High-Risk Individuals - PR Newswire

Lumiata partnered with FGC Health to use Lumiata's AI predictive models to identify high-risk patients, enabling proactive interventions and new care models. This collaboration aims to improve patient outcomes by leveraging predictive analytics.

2020-08

BioSpace

Lumiata Brings AI to the Forefront with COVID-19 Global AI Hackathon - BioSpace

Lumiata launched the COVID-19 Global AI Hackathon to address challenges posed by the pandemic and its future impact on global healthcare using artificial intelligence. The hackathon invited data scientists and other experts to develop AI solutions for the crisis.

2020-04

Frequently Asked Questions

What specific AI healthcare analytics solutions does Lumiata offer that are relevant to my practice or healthcare system?

Lumiata provides AI-driven predictive analytics that can help identify high-risk patients, forecast future healthcare costs, and predict disease onset. These insights can be used for proactive care coordination, population health management, and optimizing resource allocation within your organization.

How does Lumiata's technology help with cost prediction and risk management for patient populations?

Lumiata's predictive models analyze extensive patient data to forecast individual and population-level healthcare costs, identifying factors that drive expenses. This enables healthcare administrators to better manage financial risk, develop targeted interventions, and optimize budgeting for various patient cohorts.

What kind of patient data does Lumiata utilize, and how is data privacy and compliance (e.g., HIPAA) ensured?

Lumiata's AI models leverage a wide range of de-identified patient data, including claims, electronic health records, and other relevant clinical information. The company prioritizes data privacy and security, adhering to strict compliance standards like HIPAA to protect sensitive patient information.

Can Lumiata's predictive models assist in identifying early disease onset or managing chronic conditions more effectively?

Yes, Lumiata's AI is designed to predict the likelihood of disease onset, even for complex or rare conditions, by analyzing subtle patterns in patient data. This capability supports early intervention strategies and enhances chronic disease management programs by identifying at-risk individuals before conditions escalate.

What is Lumiata's pricing structure, and what kind of implementation support and ongoing technical assistance can we expect?

Lumiata typically offers a subscription-based pricing model, which can vary depending on the scale of implementation and specific solutions required. They provide comprehensive implementation support, including integration with existing systems, and offer ongoing technical assistance and customer support to ensure seamless operation and value realization.

How does Lumiata integrate with existing healthcare IT infrastructure and what partnerships does the company have to enhance its offerings?

Lumiata's platform is designed for flexible integration with various healthcare IT systems, including EHRs and claims processing platforms, often through APIs or other data exchange methods. The company actively pursues partnerships with other healthcare technology providers and data sources to enrich its predictive models and expand its solution ecosystem.

What is Lumiata's track record and company stability, and how does that impact long-term reliability for our organization?

Lumiata has established itself as a leader in AI-driven healthcare analytics, demonstrating a strong track record of successful deployments and positive outcomes for its clients. The company's stability and continued innovation in the AI healthcare space suggest a reliable long-term partner for organizations seeking advanced predictive analytics solutions.

Related Companies

Suggest an Edit →